Mittelbiberach, Germany

Klaus Fuchs

USPTO Granted Patents = 23 

 

 

Average Co-Inventor Count = 8.9

ph-index = 5

Forward Citations = 100(Granted Patents)


Location History:

  • Gau-Algesheim, DE (2003 - 2004)
  • Schemmerhofen, DE (2007)
  • Mittelbiberach, DE (2010 - 2015)
  • White Plains, NY (US) (2015)
  • Ingelheim Am Rhein, DE (2015 - 2019)

Company Filing History:


Years Active: 2003-2019

Loading Chart...
Loading Chart...
Loading Chart...
23 patents (USPTO):

Title: Klaus Fuchs - Innovator in Neurodegenerative Disorder Treatments

Introduction

Klaus Fuchs, based in Mittelbiberach, Germany, is a prominent inventor with a remarkable portfolio of 23 patents. His work primarily focuses on innovative solutions for treating neurodegenerative disorders, making significant contributions to pharmaceutical sciences.

Latest Patents

Among his latest inventions, Klaus has developed medications classified as inhibitors of beta-secretase. One of these patents outlines a compound known for its potential in treating disorders characterized by cognitive decline, including dementia. This invention includes both the structural formula of the compound and its pharmaceutically acceptable salts. Another notable patent addresses spirocyclic acylguanidines, detailing their effectiveness as inhibitors of the β-secretase enzyme (BACE1). These compounds are essential in creating therapeutic agents aimed at combating diseases marked by the production of β-amyloid aggregates.

Career Highlights

Klaus’s career includes significant roles in leading pharmaceutical companies such as Boehringer Ingelheim International GmbH and Vitae Pharmaceuticals, Inc. His innovative endeavors in these reputed organizations have allowed him to expand his expertise and to contribute greatly to the development of effective treatments for complex health issues.

Collaborations

Throughout his career, Klaus Fuchs has collaborated with talented professionals including Cornelia Dorner-Ciossek and Niklas Heine. These collaborations have fostered an environment of innovation and have propelled the advancement of therapeutic solutions in the medical field.

Conclusion

Klaus Fuchs stands out as a dedicated inventor whose work is pivotal in developing treatments for neurodegenerative disorders. His patents not only reflect his deep understanding of pharmaceutical sciences but also demonstrate his commitment to improving cognitive health and quality of life for individuals affected by such conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…